David Broecker
{{short description|American life sciences executive|bot=PearBOT 5}}
{{Infobox person
| name = David A. Broecker
| image =
| alt =
| caption =
| birth_name =
| birth_date = {{Birth year and age|1961}}
| birth_place =
| death_date =
| death_place =
| nationality = American
| alma_mater = Wabash College (B.A., 1983)
Massachusetts Institute of Technology (M.S., 1985)
University of Chicago (MBA, 1989)
| other_names =
| occupation = Biotechnology executive
| years_active = 1985–2017
| known_for = President and CEO of Alkermes and Indiana Biosciences Research Institute
| notable_works =
}}
David Andrew Broecker (born 1961) is an American life sciences executive. He was president and CEO of Alkermes from 2007 to 2009 and was appointed president and CEO of the Indiana Biosciences Research Institute in 2015. He left that position in 2017.{{cite news
|url= http://www.indystar.com/story/money/2015/05/19/new-ceo-bioscience-institute-looks-hire-researchers-raise-millions/
|title= New CEO of bioscience institute looks to hire researchers, raise millions
|last= Swiatek
|first= Jeff
|newspaper=Indianapolis Star
|date= May 19, 2015
|access-date=June 25, 2017}}
Education and career
Broecker graduated from Carmel High School, where he led their football team to an undefeated season and the 1978 state 3A championship, tying the Indiana High School Athletic Association record for most touchdown passes in a championship game.{{cite book
|title= The Indiana Book of Records, Firsts, and Fascinating Facts
|url= https://archive.org/details/indianabookofrec00cavi
|url-access= registration
|last= Cavinder
|first= Fred D.
|isbn=9781625840141
|publisher=Indiana University Press
|date= 1985}} He then attended Wabash College, where he majored in chemistry and led the Wabash Little Giants football team to an undefeated season in 1982.{{cite book
|title= Glory Reborn: A History of Wabash College and Its Athletic Teams
|last= Amidon
|first= James Jr.
|isbn=9780692823750
|publisher=Kerezy Communications
|date= 2017}}{{cite book
|title= The Monon Bell Rivalry: Classic Clashes of DePauw vs. Wabash
|last= James
|first= Tyler
|isbn=9781625840141
|publisher=Arcadia Publishing
|date= 2013}} Broecker won the 1982 National Football Foundation National Scholar-Athlete Award and was inducted into the Wabash College Athletic Hall of Fame twice: as an individual in 1992, and as part of the team he led in 2013.{{cite web
|url= http://sports.wabash.edu/sports/2016/1/5/FB_0105160246.aspx?path=football
|title= All-Time Football All-Americans
|publisher=Wabash College
|access-date=June 25, 2017}}
After graduating summa cum laude and Phi Beta Kappa from Wabash College in 1983, he earned a M.S. degree in chemical engineering from the Massachusetts Institute of Technology in 1985. In 1989 he earned a Master of Business Administration from University of Chicago.{{cite web|url=https://www.wabash.edu/news/story/9809|website=wabash.edu|title=David A. Broecker '83|access-date=5 December 2022}}
In 1985, Broecker joined Eli Lilly and Company, starting in the medical device and diagnostics division that later became Guidant. He was then involved in development of Ceclor, Prozac, and Zyprexa, overseeing manufacturing operations in Germany and Ireland. In 2001, he was appointed as chief operating officer of Alkermes, later serving as both president and CEO.{{cite journal
|title= People
|journal= Nature Biotechnology
|volume= 25
|issue= 4
|page= 482
|publisher=Nature Biotechnology 25, 482 (2007)
|doi=10.1038/nbt0407-482
|date= 2007
|doi-access= free
|url=http://archive.boston.com/business/healthcare/articles/2009/09/12/alkermes_chief_executive_broecker_abruptly_leaves/
|title= Alkermes chief executive suddenly leaves Cambridge biotech company
|last= Weisman
|first= Robert
|newspaper=Boston Globe
|date= September 12, 2009
|access-date=June 25, 2017}} He then held executive positions at BioCritica, ApeX Therapeutics, DiaCarta, and Harlan Laboratories. He founded Zorion Medical in 2010. He was elected a Trustee of Wabash College in 2009.{{cite web
|url= https://www.wabash.edu/news/displaystory.cfm?news_ID=7050
|title= Broecker '83 elected Trustee
|last= Amidon
|first= Jim
|publisher=Wabash College
|date= May 7, 2009
|access-date=June 25, 2017}}
In 2015, Broecker was appointed President and CEO of the Indiana Biosciences Research Institute (IBRI).{{cite web
|url=http://indianapolis.crains.com/article/bioscience-research-institute-creates-petri-dish-innovation
|title= Bioscience research institute creates a 'petri dish' for innovation
|last= O'Malley
|first=Chris
|publisher=Crain Communications
|date= June 30, 2016
|access-date=June 25, 2017}} In 2016, he announced the IBRI would focus on targeting diabetes, metabolic disease, and poor nutrition.{{cite book |last=Audretsch |first= David B. |date=2015 |title=The Oxford Handbook of Local Competitiveness
|publisher=Oxford University Press
|page=409 |isbn=9780199993307
}} In 2016, the IBRI secured $100 million in grants under his leadership.{{cite news
|url=http://www.indystar.com/story/news/2016/02/24/new-biosciences-institute-gets-100m/80794292/
|title= New biosciences institute gets $100M
|last= Rudavsky
|first=Shari
|newspaper=Indianapolis Star
|date= February 24, 2016
|access-date=June 25, 2017}} Broecker was tasked with finding a new location for the IBRI, eventually getting approval for a site to be called 16 Tech.{{cite news
|url= https://www.usatoday.com/story/news/politics/2015/11/09/city-county-council-oks-75m-indianapolis-tech-park/75475124/
|title= City-County Council OKs $75M for Indianapolis tech park
|last= Eason
|first= Brian
|newspaper=USA Today
|date= November 9, 2015
|access-date=June 25, 2017}} In 2016, Broecker announced that the IBRI had hired Rainer Fischer as Chief Scientific Officer.{{cite web
|url= http://www.insideindianabusiness.com/story/33314578/ibri-hires-european-bioscience-giant |title= IBRI hires European bioscience giant
|last= Ober
|first= Andy
|publisher=Inside INdiana Business
|date= October 4, 2016
|access-date=June 25, 2017}}{{cite news
|url= https://www.ibj.com/articles/63207-focus-biosciences-institutes-chief-scientific-officer-aims-to-foster-commercialization
|title= FOCUS: Biosciences institute's chief scientific officer aims to foster commercialization
|last= Russell
|first= John
|newspaper=Indianapolis Business Journal
|date= April 1, 2017
|access-date=June 25, 2017}} In 2017, Broecker announced that Indiana Governor Eric Holcomb reaffirmed the commitment to the IBRI made in 2013 by his predecessor Mike Pence.{{cite web
|url= http://www.insideindianabusiness.com/clip/13031931/roche-ceo-ibri-will-succeed-where-others-have-failed
|title= Roche CEO: IBRI Will Succeed Where Others Have Failed
|last= Redman
|first= Mary-Rachel
|publisher=Inside INdiana Business
|date= January 16, 2017
|access-date=June 25, 2017}}{{cite news
|url= http://www.indystar.com/story/news/politics/2017/04/21/how-gov-holcombs-priorities-fared-state-budget/100751866/
|title= How Gov. Holcomb's priorities fared in the state budget
|last= Lange
|first= Kaitlin
|newspaper=Indianapolis Star
|date= April 21, 2017
|access-date=June 25, 2017}}{{cite web
|url= http://www.wndu.com/content/news/Governor-Elect-Eric-Holcomb-releases-legislative-agenda-409828125.html
|title= Governor-elect Eric Holcomb unveils 2017 legislative agenda
|last= Heinz
|first= Katie
|publisher=WRTV
|date= January 5, 2017
|access-date=June 25, 2017}}
In September 2018, Broecker was appointed chief innovation and collaboration officer of the Purdue Research Foundation.{{cite web | url = https://www.purdue.edu/newsroom/releases/2018/Q3/veteran-entrepreneurial-leader-named-purdue-research-foundations-chief-innovation-and-collaboration-officer.html | title = Veteran entrepreneurial leader named Purdue Research Foundation's chief innovation and collaboration officer | publisher = Purdue University | date = September 12, 2018 | access-date = 2020-08-02}}
References
{{reflist}}
External links
- [https://www.bloomberg.com/research/stocks/private/person.asp?personId=753134&privcapId=141936721 David Broecker profile] at Bloomberg L.P.
- [https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=141936721 Zorion Medical profile] at Bloomberg L.P.
{{DEFAULTSORT:Broecker, David}}
Category:American business executives
Category:University of Chicago alumni